Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
NCT02317627Phase 2Completed
- Sponsor
- Kadmon
- Start
- Dec 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belumosudil in Psoriasis vulgaris (PV), sponsored by Kadmon. Started Dec 2014; status: completed.
02
Drugs
belumosudil
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT02317627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317627.